Uncategorized

Lilly to buy Kelonia for $3.25B upfront, underlining its in vivo CAR-T strategy

Published

5 hours ago

on

April 20, 2026

By

Temp User

Eli Lilly is going big on in vivo CAR-T therapy.

The company said Monday that it would buy Kelonia Therapeutics, which has a Phase 1 program for multiple myeloma and a …

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Uncategorized9 years ago

The old and New Edition cast comes together to perform

Exit mobile version